From DCAT Value Chain Insights (VCI)
Akorn, a specialty generic pharmaceutical company, has appointed Rob Monahan as senior vice president of corporate development. Mr. Monahan joins Akorn from Walgreens Boots Alliance (formerly Walgreen Company), where he was a corporate development professional focused on mergers and acquisitions (M&A) since 2009, most recently as vice president of mergers and acquisitions.
At Walgreens, Mr. Monahan was responsible for developing and executing M&A, joint ventures, and divestitures across the enterprise. Prior to Walgreens, Mr. Monahan was a member of the M&A departments at other publicly traded companies, including Option Care and Omnicare. Earlier in his career, Mr. Monahan held positions in healthcare financial advisory with increasing responsibilities at Deloitte and Lehman Brothers.
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription